Chapter 35: Anticancer Chemotherapy Drugs

Welcome to Last Minute Lecture.

This free chapter overview is designed to help students review and understand key concepts.

These summaries supplement not replaced the original textbook and may not be redistributed or resold.

For complete coverage, always consult the official text.

Welcome back to the Deep Dive.

Today we are clearing the decks.

I want you to turn off the notifications, put the phone on silent, unless you're listening on it of course, and really we are tackling a beast.

We really are.

I don't use that word lightly.

We are diving into a topic that usually makes nursing students, and honestly even seasoned pros, break out in a cold sweat.

We're talking about chapter 35,

anti -cancer drugs.

It is a dense one, but it's also one of the most critical chapters you will ever read, bar none.

Exactly.

We're doing a special edition here, tailored specifically for the learner who needs a rigorous, and I mean rigorous,

review of anti -neoplastic pharmacology.

We're working strictly from the anti -neoplastics and biologic response modifiers unit.

That's right.

The mission today is pretty specific.

We're going to decode the dense mechanisms of chemotherapy.

We're going to break down the specific drug classes, the alkylating drugs, the anti -metabolites, the anti -tumor antibiotics, the plant alkaloids, the hormones, all of them.

And then most importantly, we're going to translate all that science into clinical judgment and patient safety.

Which is really the heart of it, because when you're dealing with these drugs, the margin for error is, well, it's razor thin.

We aren't just memorizing lists today.

We're learning how to keep people alive while we administer some of the most potent and frankly dangerous medications in existence.

Love them.

Razor thin margins.

And look, before we get into the chemical weeds, I want to do a tone check, because when I was reading through this chapter,

the statistics are just heavy.

They really set the stage for why this matters so much.

They are heavy.

The text establishes the gravity immediately.

Cancer is the second leading cause of death in the United States, right behind heart disease.

The second only to heart disease.

That's huge.

It is.

And while mortality rates have decreased since the 90s, which is good news, the projection is that nearly 40 % of the population will develop cancer at some point in their lifetime.

That is a staggering number.

40%.

That means if you look around a room of 10 friends, statistically, four of them will face this diagnosis.

It's not some abstract disease.

It's personal.

It is.

And it's important to understand who is being affected because it's not uniform.

The text highlights some significant disparities.

For instance, African Americans generally have higher mortality rates from cancer than any other racial or ethnic group.

With one exception, I think.

Right.

With the exception of lung cancer in women.

But across the board, the burden is And you see higher rates of liver and stomach cancers.

Which the text links to specific infections, right?

It's not just random genetic lottery.

Correct.

And this is a key point.

Hepatitis B is a major driver for liver cancer, and Helicobacter pylori, the same bacteria that can cause ulcers, is a major driver for stomach cancer.

It shows you that cancer isn't just one thing.

It's this complex interplay of genetics, environment, and infection.

So let's define the enemy here.

We throw the word cancer around.

But biologically,

what exactly is happening?

What is going on in the cell?

At its core, cancer is unregulated growth.

It's anarchy in the cell.

It's a group of diseases where abnormal cells grow out of control and start to invade other tissues.

Usually, this all starts with some form of damage to the DNA.

And the text mentions this isn't usually a one -shot deal.

It's a multi -step process.

It's not like one little thing goes wrong and suddenly you have a tumor.

Right.

It's rarely just one gene going wrong.

To understand this, you have to look at the genetic machinery.

And there are two main players.

First, you have these things called proto -oncogenes.

Proto -oncogenes, okay.

In a healthy body, these are the good guys.

They regulate cell division, cell differentiation, and cell death, which is called apoptosis.

They tell a cell when it's time to grow and divide.

I always think of this like a car.

That is the perfect analogy.

Let's run with that.

Think of the proto -oncogenes as the gas pedal.

In a normal car, you press the gas to move and you let off to stop.

The cell divides when it needs to and then it stops.

Okay, makes sense.

Gas pedal.

But if these proto -oncogenes mutate, they become oncogenes.

The gas pedal gets stuck to the floor.

Exactly.

The proto drops off and you're left with an oncogene that is screaming at the cell to divide, divide, divide with no off switch.

But a safe car also has brakes.

The tumor suppressor genes.

Precisely.

These are the brakes.

They signal the cell to stop multiplying if things are going too fast or if the DNA is damaged.

They can even trigger that apoptosis or cell suicide if the damage is too severe to fix.

So for cancer to really take hold, you need a stuck gas pedal and you need to cut the brake lines.

That's it.

You need the oncogenes to activate and the tumor suppressor genes to fail or be lost.

And on top of all that, you might have damage to the DNA repair genes.

Let's call them the So the mutations don't get fixed in the first place.

So you have a runaway car with no brakes and no mechanic.

That is cancer.

A really vivid and scary picture.

And what triggers this damage in the first place?

Box 35 .1 in the text gave a whole laundry list of influences.

It's the collateral damage list for sure.

You have environmental factors.

Tobacco is huge, obviously linked to lung, but also kidney, pancreatic, bladder, stomach cancers.

It's a systemic poison.

Right.

Then there's asbestos, ultraviolet rays from the sun for skin cancer.

Then you have the infective agents we mentioned like HPV, the human papilloma virus causing cervical and other genital cancers or hepatitis B and C causing liver cancer.

And diet too.

I saw animal fats and alcohol on that list, which are things people consume every day.

Yes.

High intake of animal fats is linked to colon, rectum, and breast cancer.

Alcohol is linked to mouth, throat, esophagus, and liver cancer.

It's this combination of what we're exposed to, what we consume, and how our body's unique genetic machinery handles those insults over a lifetime.

Okay.

So that's the context.

That's the disease.

We have these cells dividing out of control.

Now to understand how we kill them, you always say we have to understand the life cycle of the cell itself.

You cannot, and I'll say it again, you cannot understand chemotherapy if you don't understand the cell cycle.

It is the absolute roadmap for how these drugs work.

If you don't get this, the rest of the discussion is just memorizing random names and it won't stick.

So let's visualize figure 35 .1.

We've got a circle representing the life of a cell.

Walk us through the five phases.

Okay.

Let's start at G1.

This is the first gap or the post mitotic phase.

The cell has just finished dividing and it's getting back to work.

It's growing.

It's producing RNA and the enzymes it needs for the next step.

This lasts about 15 to 18 hours.

So it's like a prep phase, gathering all the ingredients.

Exactly.

Then it moves into the S phase.

S for synthesis.

Right.

This is the big one.

This is where the DNA is actually synthesized and doubled.

The cell is making an exact copy of its entire genome.

It's an incredibly complex process and it takes 10 to 20 hours.

A lot of opportunity for things to go wrong there.

A huge opportunity, which is why the next phase is so important.

Once the DNA is doubled, we move to G2, the second gap or the pre mitotic phase.

The cell does some more growing, but critically it's checking its work.

It's proofreading the new DNA, looking for defects.

That's a quick phase, maybe three hours.

And then the main event.

The M phase, mitosis.

This is the actual physical act of division.

The duplicated chromosomes line up and are pulled apart and the cell splits into two identical daughter cells.

That's fast about an hour from start to finish.

So we have G1, S, G2, M.

That's the active cycle.

But then there's this fifth phase that seems to cause a lot of trouble for treatment, G0.

Ah, G0, the resting phase.

Most cells in the human body, your liver cells, your neurons, are actually hanging out here in G0.

They are fully functional doing their jobs, but they aren't actively dividing or preparing to divide.

They're just chilling.

They're just chilling.

And this is the crucial concept for pharmacology.

Most chemotherapy drugs are designed to target dividing cells.

They attack the processes of synthesis or mitosis.

So if a cancer cell is sleeping in G0, the drug might just swim right past it.

Precisely.

It's invisible to the drug.

It's off the radar.

And that leads us directly to how we classify these drugs.

We have two main buckets, CCNS and CCS.

Okay.

Let's unpack CCNS first.

Cell cycle nonspecific.

These are the heavy hitters.

They can act during any phase of the cell cycle.

They damage the cell's DNA directly, so it doesn't matter if the cell is in G1, SM, or even to some extent that G0 resting phase.

These include your alkylating drugs, anti -tumor antibiotics, and hormones.

They aren't picky.

Versus the CCS, or cell cycle -specific drugs.

Right.

These are more like precision instruments.

They only work during a specific phase.

They usually target either the S phase by messing with DNA synthesis or the M phase by messing with the machinery of mitosis.

These include your anti -metabolites and plant alkaloids.

And so these CCS drugs would be most effective against?

Rapidly growing tumors.

Tumors where a lot of the cells are actively moving through the cycle and not hiding out in G0.

This brings up the concepts of growth fraction and doubling time.

The text says chemotherapy works best on tumors with a high growth fraction.

Explain that for us.

Okay.

So growth fraction is just the percentage of cancer cells that are actively dividing at any given time.

So if you have a tumor with a 90 % growth fraction, that means 90 out of 100 cells are in the G1, S, G2, or M phase.

Very busy.

Very busy.

And a perfect target for chemotherapy, especially those CCS drugs.

Hematologic cancers, leukemias, lymphomas often have very high growth fractions.

They tend to respond really well and really quickly to chemo.

But solid tumors.

Like a lump in the breast or the lung.

Solid tumors are a different beast.

Especially as they get larger, they often have a much lower

A huge chunk of that tumor mass might be sitting in G0 resting and resistant to the drugs.

It's not just about how big the tumor is, but how active it is.

Exactly.

Plus as the tumor gets bigger, its blood supply gets inconsistent.

The center of the tumor might be necrotic or have poor blood flow.

If the drug can't get delivered to the cells through the bloodstream, it can't kill them.

Which explains so much about why we don't just use one drug.

We use combination chemotherapy.

We almost never use single agent therapy for most cancers anymore.

We combine drugs for three main reasons.

One, synergistic effects.

They work better together.

It's a one plus one equals three situation where each drug enhances the effectiveness of the other.

Okay, synergy.

What's number two?

To decrease or prevent drug resistance.

Cancer cells are smart.

They can mutate and figure out how to block one drug.

But it's much harder for them to develop resistance to three or four different drugs with different mechanisms of action all at once.

Got it.

And three.

To attack different phases of the cell cycle simultaneously.

You might use a CCNS drug, like an alkylating agent, to hit everything, generally.

And then you add a CCS drug, like a plant alkaloid, to specifically hammer the cells that are trying to get through the M phase.

You're attacking from all angles.

Talk to me about the logistics of giving these drugs.

The text mentions cycles.

We don't just hook them up to an IV and leave it running for a month.

No, that would be lethal.

It would kill the patient faster than the cancer.

Remember, these drugs are poisons that are slightly more toxic to cancer cells than to normal cells.

We give chemotherapy and cycles to allow the normal cells time to recover.

So we're walking a tightrope.

A very fine tightrope.

We hit the cancer hard with a cycle of chemo, then we back off for, say, two or three weeks.

In that time, we hope the bone marrow and the lining of the gut can rebuild.

Then, once the patient has recovered enough, we hit it again.

And there are different goals for the treatment.

The text defines adjuvant, neoadjuvant, and palliative.

These are terms nursing students get mixed up all the time.

Can we clarify them?

Let's do it.

Neoadjuvant is what you do before surgery.

You have a very large breast tumor, for example, that's too big for the surgeon to remove cleanly.

You give neoadjuvant chemo to shrink the tumor down to an operable size.

Neo means new or before.

Got it.

So it comes first.

Adjuvant is what you do after surgery.

The surgeon took the tumor out, and as far as they can see, the cancer is gone.

But we're worried about microscopic cells,

micrometastases that might be left behind floating around the body.

We use adjuvant chemo to mop up that residue.

The goal here is usually curative.

So adjuvant is an add -on to the main treatment.

Perfect way to remember it.

And palliative.

Palliative is when a cure is impossible.

Exactly.

The cancer is too advanced.

It's metastatic.

We use chemo not to cure the disease, but to relieve symptoms, to shrink a tumor that's pressing on a nerve causing pain or one in the lung that's causing shortness of breath.

The goal is to improve quality of life.

Okay.

That's the strategy.

Now let's talk about the cost, not the money, but the physical cost, the collateral damage.

Table 35 .2 in the text is a monster of a table, but it outlines the general side effects.

Why does chemo make people so, so sick?

It goes back to that core mechanism we talked about.

These drugs attack rapidly dividing cells.

Cancer cells divide rapidly, yes, but so do your hair follicles.

So does the epithelial lining of your entire GI tract, from your mouth to your anus.

And most importantly, so did the hematopoietic stem cells in your bone marrow.

Bone marrow suppression,

myelosuppression.

This feels like the biggest safety red flag in the entire chapter.

It's mentioned with almost every drug.

It is the number one dose limiting toxicity for most of these drugs.

It's the side effect that forces us to stop or delay treatment.

If you wipe out the bone marrow, you wipe out the body's ability to make blood cells, and you need to know the term nadir, N -A -D -I -R.

The nadir, that's the low point, right?

Yes.

It's the point in time after a chemo cycle where the blood counts are at their absolute lowest.

Typically this happens about seven to 10 days after treatment.

This is when the patient is most vulnerable to the consequences of myelosuppression.

And we break this down into three categories based on the cell line.

First up, white blood cells, leukopenia, or more specifically, neutropenia.

This is a life -threatening emergency waiting to happen.

Neutrophils are your body's first line of defense against bacteria.

If you don't have them, you can't fight infection.

A simple cold, a tiny cut, bacteria from your own gut can become a raging, fatal sepsis in a matter of hours.

The text really emphasizes safety here.

Fever is the major, sometimes the only, sign.

If a chemotherapy patient calls you or comes into the ER with a temperature greater than 101 degrees Fahrenheit or 38 .3 Celsius, that is a drop -everything -and -call -the -provider moment.

That is a medical emergency.

You do not wait.

Even a low -grade fever in a neutropenic patient can be a sign of impending septic shock.

And the patient education is critical.

We teach them.

Meticulous hand hygiene.

Avoid crowds.

Avoid sick people.

No fresh flowers or raw fruits and vegetables that might carry bacteria or fungi.

Exactly.

It's called a neutropenic diet.

And if the counts get too low, we can intervene.

We can give injections of colony -stimulating factors like filgrastem or pegfilgrastem to stimulate the bone marrow to produce more white blood cells.

Okay, that's white cells.

Next line, red blood cells, anemia.

Low red blood cells means low hemoglobin, which means low oxygen -carrying capacity.

The patient will experience profound fatigue, shortness of breath on exertion, maybe look pale or even cyanotic.

Their heart might race as it tries to compensate.

And the treatment for that?

It depends on the severity.

We encourage them to space out their activities, take rest periods.

For more severe anemia, we might need to give a blood transfusion or use drugs like EPO or therpoietin to stimulate RBC production.

And the third and final cell line, platelets,

thrombocytopenia.

This is your bleeding risk.

Platelets are what?

Plug holes in blood vessels.

Without them, you can bleed spontaneously.

You as the nurse need to look for signs like patechiae, those little red or purple pinpoint dots on the skin, especially in the legs.

Easy bruising, bleeding gums when they brush their teeth,

nosebleeds that won't stop.

And the nursing cautions here are strictly do no harm.

It's all about prevention.

Right.

No invasive procedures if you can help it.

No intramuscular injections.

They can cause a huge hematoma.

And absolutely no rectal temperatures, no suppositories, no enemas.

The rectal mucosa is very fragile and you do not want to cause bleeding there.

We teach them to use a sock bristle toothbrush, use an electric razor instead of a blade.

Moving from the marrow to the gut.

The GI disturbances are probably what patients fear the most.

It are.

The entire GI tract is lined with rapidly dividing epithelial cells and chemo just annihilates them.

Plus, many of these drugs are immunogenic, meaning they trigger the chemoreceptor trigger zone or CTZ in the brain.

So you get this double whammy of direct gut toxicity and essential nervous system trigger for nausea and vomiting.

What's the key nursing move here?

It's all about timing, isn't it?

It's all about timing pre -medicate.

You give the anti -medics, the ondansetron, the apripetent, the steroids before the chemo starts.

Then you give it during the infusion and you send them home with a schedule to take it for several days after.

Do not wait for them to start vomiting.

Once that reflex starts, it's very hard to stop.

And simple things like removing strong odors from the room.

Huge.

The smell of food from the hallway can be enough to trigger it.

Keep things bland, keep things cool.

And then there's stomatitis or mucositis, the mouth gets horribly inflamed.

It can be truly debilitating.

The entire mucous membrane can become red, raw and ulcerated.

It can have white patches of candida or thrush.

It makes eating, drinking, even talking impossible.

So what can we do?

Meticulous, frequent mouth care is key.

Tintel rinses with plain saline solution every couple of hours.

We tell them to avoid any commercial mouth washes that contain alcohol that burns like fire on raw tissue.

A very soft toothbrush or a toothette.

Ice chips during the infusion of certain drugs can help constrict blood vessels and reduce uptake in the mouth.

And diarrhea is the other end of the problem.

Yes, for the same reason, damage to the gut lining.

The text makes a good point to avoid very hot or very cold foods because those temperature extremes can stimulate peristalsis and make it worse.

We need to keep the gut calm and monitor their electrolytes very closely because you can lose a lot of potassium and become dangerously hypokalemic.

Finally, let's talk about the side effects that are visible to the entire world.

Alopecia and infertility.

Hair loss alopecia is temporary but can be incredibly traumatic for a patient's body image and sense of self.

It usually starts about two to three weeks after the first treatment and it often grows back after chemo is done, sometimes with a different color or texture.

The key is to prepare them.

We talk about wigs, scarves, or hats before the loss happens so they feel like they have some control.

And infertility.

This one isn't temporary.

It can be permanent and it's a devastating consequence, especially for younger patients.

We have to have these difficult conversations up front before we start the first dose of treatment.

We have to counsel them about fertility preservation options like sperm banking for men or egg or embryo freezing for women.

It's a critical part of the nursing role.

Okay, that is the broad landscape of toxicity.

It's a lot to manage.

Now we are going to march through the specific drug classes.

We'll start with the alkylating drugs.

The alkylating agents.

So these are cell cycle non -specific CCNS.

They work by adding an alkyl group to the DNA, which causes the DNA strands to cross -link.

What does that mean, cross -link?

Imagine trying to unzip a zipper that has been super glued shut.

The two sides of the DNA helix can't separate.

And if they can't separate, the DNA can't be replicated.

The cell can't divide.

And it eventually undergoes poptosis.

So it gums up the works.

The prototype here in the text is cyclophosphamide.

Right.

Cyclophosphamide is a nitrogen mustard derivative.

It's a workhorse drug used for many things.

Lymphomas, leukemias, breast, and ovarian cancer.

And it's also used as an immunosuppressant for autoimmune diseases like SLE or lupus.

A key point is that it's a prodrug, meaning the liver has to metabolize it to turn it into its active cancer -killing form.

Now, there is one very specific, very nasty adverse effect with cyclophosphamide that shows up in every nursing exam I've ever seen.

Hemorrhagic cystitis.

Yes.

This is the big red flag for this drug.

As the liver breaks down cyclophosphamide, it creates these neurotoxic metabolites.

These metabolites get concentrated in the urine, they sit in the bladder, and they literally chew up the bladder lining.

It causes severe inflammation, irritation, and bleeding.

It sounds horrific.

How do we prevent it?

There are two key strategies.

First is hydration.

Aggressive hydration.

The patient needs to drink at least two liters of fluid a day to keep the urine dilute and to keep flushing those toxins out.

They need to empty their bladder frequently every two to three hours, even waking up at night to do so.

We don't want that toxic urine just sitting there.

And the timing of the dose matters.

It does.

We always tell them to take the oral dose early in the day.

You don't want to take it right at bedtime and then have it accumulating in your bladder all night long while you sleep.

And there's a drug, a specific antidote or protectant, that helps.

Yes.

It's called Mezna.

Mezna is a chemoprotectant.

It's given IV right along with the cyclophosphamide, and it binds to those toxic metabolites in the urine and inactivates them, rendering them harmless.

It's a bladder shield.

So cyclophosphamide equals bladder protection, hydration and Mezna.

Got it.

Any important interactions we need to be aware of.

The text specifically warns about a number of herbal supplements.

Garlic, Ginkgo, Echinacea, and St.

John's wort can all interfere with its metabolism.

Also, thiazide diuretics can prolong the leukopenia, so you have to be cautious with that combination.

Before we leave alkylating drugs, the text also mentions the platinum drugs, cisplatin and carboplatin.

Right.

They are considered alkylating -like.

They also work by cross -linking DNA.

They are very effective, but cisplatin in particular is infamous for being highly hematogenic, causes severe nausea, and for causing significant renal toxicity and peripheral neuropathy.

You really have to push fluids with cisplatin to protect the kidneys.

Okay, let's move to the next class.

The anti -metabolites.

The anti -metabolites.

These are the opposite of the alkylating agents in one key way.

They are CCS, cell -cycle specific.

They mostly do their damage in the S phase, when the cell is actively trying to synthesize new DNA.

I like to call these the counterfeit drugs.

That's a perfectly accurate description.

They are designed to structurally resemble the normal building blocks, the metabolites, that the cell needs to build DNA and RNA, things like folic acid or the pyrimidines and purines.

So the cell gets tricked.

The cell gets tricked.

It grabs the anti -metabolite drug, thinking it's a legitimate building block.

It tries to incorporate it into the new DNA strand, but it's a fake.

It doesn't fit right.

It jams up the whole replication machinery, and DNA synthesis grinds to a halt.

Let's talk about the first prototype here.

Fluorosil or 5 -FU.

5 -FU is a pyrimidine analog.

It's a cornerstone treatment for many solid tumors, especially GI cancers like colon, stomach, and pancreatic cancer, as well as breast cancer.

It can also be used topically as a cream for certain types of skin cancer.

What are the big red flags, the key toxicities for 5 -FU?

Well, it causes the standard myelosuppression and GI issues.

In fact, stomatitis soreness in the mouth can be an early warning sign of systemic toxicity.

But the unique one here, the one you really need to associate with 5 -FU, is hand and foot syndrome.

The dreaded palmar plantar erythrodisiasthesia.

That's the one.

It's a fancy term for painful, swollen, red palms and soles.

It can start with just tingling or a feeling of heat, but it can progress to blistering, cracking, and peeling skin.

It's very uncomfortable and can limit a patient's ability to walk or use their hands.

And what about interactions?

The texts mention leukovirin, but in a weird way.

This is a really important and often confusing point.

Leucovirin is used with 5 -FU to potentiate it, to make it work better.

Leucovirin helps 5 -FU bind more tightly to its target enzyme, increasing its cancer -killing effect.

This is the complete opposite of how we use leucovirin with our next drug, methotrexate.

Which is the perfect segue.

Let's talk about methotrexate.

This is a folic acid antagonist.

Right, methotrexate works by blocking a key enzyme called dihydrofolate reductase.

This enzyme is essential for converting folic acid into its active form.

Without active folate, the cell can't make the building blocks for DNA, specifically thymidine.

So again, DNA synthesis stops.

It's used for cancer, but it has a lot of other uses too, right?

It does.

In much lower doses, it's a common treatment for autoimmune diseases like rheumatoid arthritis and severe psoriasis.

It's also used to treat ectopic pregnancies.

But in the high doses we use for cancer, it's extremely toxic.

Extremely.

It affects all high metabolic cells, not just cancer.

The bone marrow, the GI tract, all get hammered.

The rescue drug here is absolutely critical.

It's leucovirin.

Okay, so explain the rescue.

Why does leucovirin work here?

Because methotrexate blocks the activation of normal folic acid, the healthy cells in the body start to die too.

We give a high dose of methotrexate to kill the cancer, and then at a specific time later, we administer leuculorin.

Leucovirin is a form of folate that is already active.

It doesn't need that enzyme that methotrexate is blocking.

So it effectively bypasses the blockade and rescues the normal healthy cells from the toxic effects.

But the text has a huge all caps warning here.

Do not confuse leucovirin with folic acid.

This is a potentially fatal error.

If you accidentally give a patient on high dose methotrexate regular folic acid instead of leucovirin, you're just providing more fuel for the fire.

The enzyme is still blocked, so the folic acid is useless, and it can actually worsen the toxicity.

It has to be leucovirin.

What about other interactions for methotrexate?

NSAIDs.

This is a huge one.

Patients might want to take ibuprofen or naproxen for pain or fever,

but NSAIDs can decrease the renal clearance of methotrexate, causing its levels to build up in the body to a severe, even fatal level of toxicity.

Also, proton pump inhibitors, PPIs and penicillins, can increase its toxicity.

And you have to keep the urine alkaline, right?

Yes, very important.

Methotrexate can crystallize in acidic urine, causing severe kidney damage.

We often give sodium bicarbonate to alkalinize the urine and ensure the drug is excreted safely.

Okay, moving on to the next major class, anti -tumor antibiotics.

Right.

And the first clarification is always, these are not for treating your sinus infection.

They are called antibiotics, because they were originally isolated from soil fungi.

But their purpose is to kill cancer cells, not bacteria.

They are mostly CCNS, non -specific.

The prototype here is doxorubicin.

Doxorubicin and anthracycline.

I've heard this called the red devil, but the text just mentions the red urine.

It does.

A very common and expected side effect is that the drug will turn the patient's urine and other body fluids a pink or reddish color for a day or two after the infusion.

This is just the drug dye, it's not blood.

You absolutely have to warn the patient about this beforehand, or they will be terrified.

But the real danger isn't the color.

The real danger is the heart.

Partiotoxicity.

This is the dose -limiting, life -threatening toxicity of doxorubicin.

It can cause permanent damage to the heart muscle, leading to acute arrhythmias, or a chronic, irreversible cardiomyopathy and heart failure, sometimes years after the treatment has ended.

Is it dose -dependent?

Is there a limit?

It is absolutely dose -dependent.

There is a cumulative lifetime dose limit, which the text states is typically around 550 milliliters to.

Every single dose the patient ever receives must be tracked.

Once you hit that lifetime limit, you generally can never have doxorubicin again.

And just like with cyclophosphamide, there's a protectant for this one too.

There is, it's called dexorzoxane.

It's a chemoprotectant that can be given before the infusion, specifically to help shield the heart muscle from the drug's damaging effects.

So cyclophosphamide has mezna for the bladder,

doxorubicin has dexorzoxane for the heart.

These are key associations.

Correct.

And you must always, always monitor the IV site with doxorubicin.

It is a severe vesicant.

If it leaks out of the vein, a process called extravasation, it causes terrible deep tissue necrosis that can require surgical debridement.

If the patient complains of any pain or burning at the site, you stop the infusion immediately.

Any other antibiotics we should note from the chapter?

Bleomycin is an important one.

The red flag for bleomycin isn't the heart, it's the lungs.

It can cause dose -related pulmonary fibrosis, a scarring of the lung tissue that is irreversible.

You need to monitor for any cough or shortness of breath.

Okay, next category,

the plant alkaloids.

Nature is a powerful pharmacologist.

These drugs are derived from plants like the periwinkle, the yew tree, and the mandrake.

They are all CCS cell cycle specific and they work in the M phase.

They essentially freeze the cell during mitosis so it can't complete the division process.

The prototype here is vincristine.

Right, vincristine is a vinca alkaloid from the periwinkle plant.

What's the major dose -limiting toxicity for vincristine?

Neurotoxicity.

This drug is famous for damaging peripheral nerve fibers.

What does that actually look like in a patient?

What would a nurse assess for?

You'd assist for numbness and tingling, especially in the fingers and toes, that classic stocking glove pattern.

You would check their deep tendon reflexes, which will become diminished or absent.

You'd watch their gait for a taxia or foot drop where they can't lift the front of their foot.

And it affects the autonomic nerves too, not just the sensory ones.

Yes, and this is critical.

It can cause severe constipation, which can progress to a paralytic ileus where the gut just stops moving entirely.

So assessing bowel sounds and function is a top priority for any patient on vincristine.

But there's a very unique silver lining with vincristine, isn't there?

There is.

It is marrow sparing.

Unlike almost all the other cytotoxic drugs we've discussed, it causes very little bone marrow suppression.

This makes it an excellent drug to use in combination regimens with other drugs that do heavily suppress the marrow.

What about safety with administration?

There's a huge alert in the book about this.

A black box warning.

It is fatal if given intrathecally into the cerebrospinal fluid in the spine.

It causes massive irreversible neurotoxicity and death.

It must only be given via the IV route.

And many hospitals have special protocols, like never putting it in a syringe to prevent this error.

And it is also a vesicant.

So you have to watch that IV site closely.

Any other plant alkaloids to quickly mention?

The taxines, like paclitaxel and docetaxel derived from yew trees, are very important.

The main thing to watch for with them is severe hypersensitivity or allergic reactions during the infusion.

And then there's irinotechin, camptothicin, which is used for colorectal cancer.

The major issue there is severe life -threatening diarrhea.

We have a memory trick for that one, right?

The students always say, I run to the can for irinotechin.

It causes a severe cholinergic diarrhea that can be immediate and profound.

OK, we're through the really heavy cytotoxic stuff.

Yeah.

Let's finish the drug classes with hormones and hormonal antagonists.

Right.

So this is a totally different mechanism of action.

Hormones aren't cytotoxic in the same way.

They don't directly kill the cells.

They work by either blocking the hormones that a tumor needs to grow or by providing a hormonal environment that is hostile to the tumor.

Corticosteroids first, prednisone, dexamethasone, they seem to be in every regimen.

We use them a lot.

They are anti -inflammatory.

They suppress the immune system, which can be helpful in lymphomas and leukemias.

And they're also potent antimetics.

But the side effects are numerous.

The text lists a whole bunch.

Hyperglycemia is a big one.

They raise blood sugar,

insomnia, fluid retention, mood changes, or irritability, what people call roid rage.

And because they suppress the immune system, they can mask the signs of an infection.

A patient could have a severe infection brewing, but have no fever because of the steroids.

Then we get into the sex hormones, targeting hormone receptor -positive cancers like breast and prostate.

Let's start with tamoxifen.

Tamoxifen is a CIRM, a selective estrogen receptor modulator.

It's been a gold standard for estrogen receptor -positive breast cancer for decades.

It works by sitting in the estrogen receptors on the tumor cells, blocking real estrogen from getting in and fueling the tumor's growth.

But blocking estrogen has consequences elsewhere in the body.

It does.

It can cause menopausal -like symptoms like hot flashes.

But more dangerously, while it blocks estrogen in the breast, it actually stimulates it in the uterus.

This increases the risk of uterine malignancy or endometrial cancer.

And it also increases the risk of thrombotic events, blood clots, DVTs, and pulmonary emboli.

And what about the aromatase inhibitors like anastrazole?

These are a different approach.

They are used in postmenopausal women.

In these women, the ovaries have stopped working, but they still produce some estrogen because an enzyme called aromatase in their fat and adrenal tissues converts androgens into estrogen.

These drugs block that enzyme, shutting down estrogen production.

Before we hit the case study, just a quick nod to the future therapies section.

The text mentions vaccines and targeted therapies.

Right.

We have vaccines that can actually prevent cancer.

The hepatitis B vaccine can prevent liver cancer.

The HPV vaccine can prevent cervical and other genital cancers.

And then there's a therapeutic vaccine, cipulacel -T, which is a form of immunotherapy for prostate cancer.

It trains the patient's own immune system to attack the cancer.

Okay.

We have covered the entire map.

That was a marathon.

Now let's put on our clinical judgment hats and make this real.

We have a case study from the text.

This is the synthesis.

We have a 43 -year -old female with metastatic colorectal cancer.

She's on a common regimen called BOLUS -IFL, which stands for urinotechin, 5 -FU, and leukovorin.

She comes into the clinic for her third cycle of treatment.

We do our nursing assessment.

I'm going to throw some of the assessment findings at you.

You tell me, based on her drug regimen, is this an expected finding that we just monitor, or is this a follow -up required situation, meaning a red flag we need to act on immediately?

Symptom number one, her temperature is 99 .3 degrees Fahrenheit.

Follow -up required.

Immediately.

But 99 .3 isn't technically a fever.

A lot of places define fever as 100 .4 or higher.

Doesn't matter.

In a chemo patient on myelosuppressive drugs like 5 -FU and urinotechin, any elevation, any trend upwards, is a potential sign of neutropenic fever and sepsis.

The trend matters.

You don't ignore it.

You report it.

Okay.

Red flag number one.

Symptom number two.

She complains of new onset right upper quadrant RUQ abdominal pain.

Follow -up required.

5 -FU is metabolized by the liver.

RUQ pain is a classic sign of liver toxicity or inflammation.

We need to investigate that.

Symptom number three.

Her heart rate is 94.

And you notice some irregularities in PVCs on her ECG monitor.

Follow -up required.

5 -FU is known to have cardiotoxic potential.

Any new arrhythmia or irregularity is a serious warning sign that needs to be worked up before we give another dose of a potentially cardiotoxic drug.

Symptom number four.

She tells you that her hands and feet feel hot and tingly.

Follow -up required.

That is the classic prodroma symptom, the very beginning of palmar plantar erythrodysesthesia or hand and foot syndrome from the 5 -FU.

It starts with that heat and tingling before it progresses to redness, swelling, and pain.

We need to catch it early and maybe adjust the dose.

Okay.

Final one.

Symptom number five.

She reports feeling nauseous, but says she's able to keep down small amounts of food and fluids.

That one I would say is monitor.

Nausea is an expected side effect of this regimen.

If she's still tolerating some intake and isn't dehydrated, we would continue to manage her symptoms with antimedics and education.

It's not an emergency red flag like the others.

This really highlights that the nurse isn't just a machine giving drugs.

The nurse is the detective.

You are the early warning system.

You have to know specifically what each drug does, what its unique toxicities are, to be able to catch these subtle signs before they become full -blown catastrophes.

Let's wrap this entire deep dive up.

We've covered an immense amount of ground.

If the listener takes away nothing else, what are the big three general toxicities to watch for with almost any cytotoxic chemo?

One, bone marrow suppression.

That means risk for infection, anemia, and bleeding.

Two, GI tract injury.

That's your nausea, vomiting, mucusitis, and diarrhea.

And three,

skin and hair effects like alopecia.

Those are your universal constants.

And now let's do a rapid -fire review of the specific drug red flags we talked about, the one thing you have to link to each drug.

Let's do it.

Cyclophosphamide.

Bladder.

Hemorrhagic cystitis.

Hydrate.

Doxoribicin.

Heart.

Cardiotoxicity.

And Christine.

Nerves.

Neurotoxicity.

And 5 -FU.

GI tract and hand and foot syndrome.

It's a lot of poison we're putting into people.

The whole chapter is just a catalog of toxicity.

It is.

And I think I want to leave you with this final thought.

The goal of pharmacology isn't just to kill the cancer, it's to preserve the patient.

It's a constant, delicate balance between curing the disease and maintaining a life that is worth living.

And as a nurse, you are the person who manages that balance.

You aren't just administering the poison, you are managing the person's survival through the side effects.

You are the one protecting their kidneys with IV fluids, protecting their heart with careful monitoring, protecting their gut with perfectly timed antimedics, and protecting their dignity when they lose their hair.

That is the real art and science of oncology nursing.

Powerful.

Thank you for walking us through this absolute minefield.

My pleasure.

It's critical information.

And to you, the learner, thank you for surviving this deep dive.

Take a deep breath.

You've got this.

This is the Last Minute Lecture Team signing off.